Email Us
View Reports

Cancer Drugs Market

Cancer Drugs Market Analysis – By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy) – By Cancer type (Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer)- By Geography (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) – Size, Share, Growth and Global Forecast to 2025

  • ID : 1017849673  |  
  • Published : May-2019  |  
  • Region : Global  |  
  • Pages : 150   |  
  • Publisher : Research Cosmos

Cancer Drugs Market Overview:

Recent advances in biological therapies have extended the scale of therapeutic targets for cancer treatment with the identification of tumor-specific genes. Immunotherapies and biological products are becoming potential to find a permanent cure for several types of cancer. Among the various biological products, drugs with monoclonal antibodies have attracted attention in recent years due to their high efficacy.

Cancer Drugs Market Size Expected to Reach USD 169.20 Billion by 2025, developing at a CAGR of almost 8.4% from 2018 to 2025.

Factors Driving the Cancer Drugs Market:

The global market for anti-cancer drugs is mainly driven due to the growing number of different cancers, such as breast cancer, lung cancer and cervical cancer worldwide. Another important stimulating factor is the growth of research and the development of targeted and biological pharmacological therapies for the treatment of cancer. On the other hand, strict regulatory policies and the high cost of drug development, together with the risk of failure, are the main limitations that could hinder the development of the market for cancer drugs.

Cancer Drugs Market Insights and Opportunities:

The global market for cancer drugs according to the therapeutic modalities is segmented into chemotherapy, targeted therapy, immunotherapy, hormonal therapy, etc. Immunotherapy dominates the world market for anti-cancer drugs due to its high efficacy and fewer side effects.

Monoclonal antibodies such as trastuzumab, bevacizumab and rituximab are potential immunotherapeutic agents that have led to magnanimous sales. The market for cancer immunotherapy is mainly based on the huge investments in research of multinational companies and research collaborations for the development of immunological therapy against cancer. In recent years, treatments directed against cancer have attracted special attention due to their specific action of tumor cells to protect healthy cells from the toxic effects of cancer drugs.

The world market for cancer drugs by type of cancer is segmented into blood cancer, breast cancer, cancer of the digestive tract, prostate cancer, lung cancer, skin cancer and other cancers. Among these different types of cancer, blood cancer was the segment that generated the most income in 2015.

The growth of the blood cancer segment is mainly due to the high cost of medicines used in the treatment. The prevalence of blood cancer is lower in developed countries, however, the diagnosis rate is over 90% and almost all people diagnosed with blood cancer seek a complete cure. Due to the high disposable income of consumers in developed countries, expensive pharmacotherapy for blood cancer is affordable in these areas. Most recently developed biologics have shown a significant cure for blood cancer, therefore, the rate of use of these drugs is high, despite its high cost.

Cancer Drugs Market Geographical Insights:

Europe, North America, Latin America, Asia-Pacific, and Middle East and Africa are the major geographical segments of the world market for cancer drugs. North America is expected to remain the dominant region for years to come. The requirements for anticancer drugs were particularly important in North America, more precisely in the United States. Asia-Pacific is likely to be the fastest growing region of the market for cancer drugs in the coming years. In addition, Latin America, the Middle East and Africa are also expected to experience moderate growth in the market for anti-cancer drugs in the coming years.

Prominent Players Covered in this Cancer Drugs Market report are:

  • Johnson & Johnson
  • Amgen Inc.
  • Eli Lilly & Co.
  • GlaxoSmithKline
  • Novartis AG
  • Roche diagnostics
  • Merck & Co.
  • Pfizer
  • Celgene Corporation.
  • Roche
  • Sanofi
  • Novartis
  • Celgene

Detailed Segmentation of Cancer Drugs Market:

Cancer Drugs Market –By Therapy:

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormonal Therapy

Cancer Drugs Market – By Cancer type:

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer

Cancer Drugs Market - By Regions:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents:

  1. Introduction                                                                      
  2. Research Methodology                                                                   

    1. Analysis Design                                             

      1. Research Phases                                                            
      2. Secondary Research                                  
      3. Primary Research                                      
      4. Expert Validation                                       

    2. Study Timeline                                                

  3. Overview                                                                         

    1. Executive Summary                                                      
    2. Key Inferences                                                
    3. New Developments                                                      

  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                             

    1. Cancer Drugs Market Drivers                                                
    2. Cancer Drugs Market Restraints                                                         
    3. Key Challenges                                               
    4. Current Opportunities in the Cancer Drugs Market

  5. Cancer Drugs Market Segmentation                                                                    
  6. Cancer Drugs Market –By Therapy:

    1. Immunotherapy
    2. Targeted Therapy
    3. Chemotherapy
    4. Hormonal Therapy

  7. Cancer Drugs Market – By Cancer type:

    1. Breast Cancer
    2. Blood Cancer
    3. Gastrointestinal Cancer
    4. Prostate Cancer
    5. Skin Cancer
    6. Lung Cancer

  8. Geographical Analysis                                                                    

    1. North America                                               

      1. Introduction                                
      2. United States                              
      3. Canada                                       

    2. Europe                                                           

      1. Introduction                                
      2. United Kingdom                                         
      3. Germany                                      
      4. France                                        
      5. Italy                             
      6. Spain                                           

    3. Asia-Pacific                                                   

      1. Introduction                                
      2. China                                           
      3. India                                           
      4. Japan                                          
      5. South Korea                                

    4. Latin America                                                 

      1. Introduction                              
      2. Brazil                                           
      3. Argentina                                   
      4. Mexico                                       

    5. Middle-East & Africa                                                     

      1. Introduction                               
      2. Middle-East                                
      3. Africa                                         

  9. Strategic Analysis                                                             

    1. PESTLE analysis                                             

      1. Political                                     
      2. Economic                                   
      3. Social                                          
      4. Technological                              
      5. Legal                                          
      6. Environmental                                            

    2. Porter’s five analysis                                                    

      1. Bargaining Power of Suppliers                                   
      2. Bargaining Power of Consumers                               
      3. Threat of New Entrants                             
      4. Threat of Substitute Products and Services                               
      5. Competitive Rivalry within the Industry          

    3. Supply Chain Analysis

      1. Raw Material Suppliers
      2. Manufacturers/Producers
      3. Distributors/Retailers/Wholesalers/E-Commerce
      4. End Users

  10. Cancer Drugs Market Leaders' Analysis      

    1. Johnson & Johnson

        1. Product Analysis                           
        2. Strategic Evaluation and Operations                                          
        3. Financial analysis                                        
        4. Legal issues                                
        5. Recent Developments                               
        6. SWOT analysis                                           
        7. Analyst View      

    2. Amgen Inc.
    3. Eli Lilly & Co.
    4. GlaxoSmithKline
    5. Novartis AG
    6. Roche diagnostics
    7. Merck & Co.
    8. Pfizer
    9. Celgene Corporation.
    10. Roche
    11. Sanofi
    12. Novartis
    13. Celgen

  11. Competitive Landscape                                                                   

    1. Cancer Drugs Market share analysis                                                    
    2. Merger and Acquisition Analysis                                                  
    3. Agreements, collaborations and Joint Ventures                                                          
    4. New Product Launches                                                   

  12. Expert Opinions                                                             

    1. Cancer Drugs Market Outlook                                                            
    2. Investment Opportunities                                                            

  13. Appendix                                                             

    1. List of Tables                          
    2. List of Figures

Purchase this Market Research Report


Call us on : +1 888 709 8757

Drop us an email at :